Keyword Analysis & Research: regeneron
Keyword Research: People who searched regeneron also searched
Search Results related to regeneron on Search Engine
-
Regeneron Pharmaceuticals: Delivering Life-transforming Medicines
https://www.regeneron.com/
WEBRegeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
DA: 56 PA: 62 MOZ Rank: 83
-
About Regeneron Pharmaceuticals: Innovative Biotechnology
https://www.regeneron.com/about
WEBReinventing Drug Discovery. For 35 years, our mission has been to use the power of science to bring new medicines to patients… over and over again. Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases.
DA: 19 PA: 31 MOZ Rank: 58
-
Regeneron's Industry-Leading Biotechnology - Pushing The …
https://www.regeneron.com/global
WEBRegeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need. Explore Regeneron's global presence.
DA: 13 PA: 34 MOZ Rank: 70
-
Regeneron Pharmaceuticals - Wikipedia
https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals
WEBRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase ...
DA: 35 PA: 79 MOZ Rank: 12
-
Regeneron Pharmaceutical's Pipeline & Medicines
https://www.regeneron.com/pipeline-medicines
WEBOur goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our pipeline is powered by end-to-end research and development capabilities, and our commitment to operational excellence and patient safety ensures we consistently produce the highest-quality medicines.
DA: 16 PA: 14 MOZ Rank: 79
-
Regeneron’s COVID-19 Response Efforts
https://www.regeneron.com/covid19
WEBMonitor SARS-CoV-2 variants with Regeneron’s COVID-19 Dashboard. Refreshed daily with new genomes and associated patient metadata. Learn how Regeneron is actively working on testing existing medicines and developing new …
DA: 19 PA: 55 MOZ Rank: 23
-
Regeneron's Portfolio of Approved Medicines
https://www.regeneron.com/pipeline-medicines/approved-medicines
WEBRegeneron's goal is to address serious medical conditions, across multiple and diverse therapeutic areas. View our portfolio of FDA-approved medicines here. Our antibody …
DA: 73 PA: 98 MOZ Rank: 26
-
Resources and Information for Patients: REGENERON
https://www.regeneron.com/patients
WEBFind resources and information geared specifically toward patients and learn about REGENERON's innovative medicines, community support and more.
DA: 66 PA: 89 MOZ Rank: 86
-
Regeneron Announces Formation of Regeneron Cell Medicines …
https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-formation-regeneron-cell-medicines
WEBTARRYTOWN, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio, Inc. to acquire full development and commercialization rights to its pipeline of investigational novel immune cell therapies, along with its ...
DA: 32 PA: 84 MOZ Rank: 1
-
Investor Relations | Regeneron Pharmaceuticals Inc.
https://investor.regeneron.com/
WEB1 day ago · Regeneron to Report First Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on May 2, 2024 News: Mar 25 Regeneron Provides Update on Biologics License Application for Odronextamab
DA: 53 PA: 1 MOZ Rank: 77
